Inter-observer variability in the histological assessment of colorectal polyps detected through the NHS Bowel Cancer Screening Programme

Histopathology

Volumn 61, Issue 1, 2012, Pages 47-52

  Foss, Fiona A ^a   Milkins, Steve ^b   Mcgregor, Angus H ^c  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

^b KETTERING GENERAL HOSPITAL   (United Kingdom)

^c LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Adenocarcinoma; Colorectal adenoma; Histopathology; Inter observer variability; NHS Bowel Cancer Screening Programme; Polyp

Indexed keywords

ARTICLE; CANCER SCREENING; COLORECTAL POLYP; DYSPLASIA; HISTOPATHOLOGY; INTESTINE CANCER; PRIORITY JOURNAL;

ADENOCARCINOMA; ADENOMA, VILLOUS; COLONIC POLYPS; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; GREAT BRITAIN; HUMANS; MASS SCREENING; NEOPLASM INVASIVENESS; OBSERVER VARIATION; PROGNOSIS; RETROSPECTIVE STUDIES; STATE MEDICINE;

EID: 84862868663     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2011.04154.x     Document Type: Article

References (24)

1. NHS Bowel Cancer Screening Programme., 2010 (accessed February 2011).
2. UK Colorectal Cancer Screening Pilot Team. Evaluation of the UK Colorectal Cancer Screening Pilot. Final report., 2003 (accessed February 2011).
3. Towler B, Irwig L, Glasziou P, Kewenter J, Weller D, Silagy C. A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, Hemoccult. Br. Med. J. 1998; 317; 559-565.
4. Hardcastle JD, Chamberlain JO, Robinson MHE et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996; 348; 1472-1477.
5. Weller D, Moss S, Butler P et al. English Pilot of Bowel Cancer Screening: an evaluation of the second round. Final Report to the Department of Health, February 2006 (revised August 2006). (accessed February 2011).
6. Yoon H, Martin A, Benamouzig R, Lonchampt E, Deyra J, Chaussade S. Inter-observer agreement on histological diagnosis of colorectal polyps: the APACC study. Gastroenterol. Clin. Biol. 2002; 26; 220-224.
7. Cross SS, Betmouni S, Burton JL et al. What levels of agreement can be expected between histopathologists assigning cases to discrete nominal categories? A study of the diagnosis of hyperplastic and adenomatous colorectal polyps. Mod. Pathol. 2000; 13; 941-944.
8. Jensen P, Krogsgaard MR, Christiansen J, Brændstrup O, Johansen A, Olsen J. Observer variability in the assessment of type and dysplasia of colorectal adenomas, analyzed using kappa statistics. Dis. Colon Rectum 2005; 38; 195-198.
9. Cross SS. Kappa statistics as indicators of quality assurance in histopathology and cytopathology. J. Clin. Pathol. 1996; 49; 597-599.
10. Brown LJ, Smeeton NC, Dixon MF. Assessment of dysplasia in colorectal adenomas: an observer variation and morphometric study. J. Clin. Pathol. 1985; 38; 174-179.
11. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33; 159-174.
12. Altman D. Practical statistics in medical research. London: Chapman and Hall, 1993; 403-409.
13. Silcocks PB. Measuring repeatability and validity of histological diagnosis-a brief review with some practical examples. J. Clin. Pathol. 1983; 36; 1269-1275.
14. Denis B, Peters C, Chapelain C et al. Diagnostic accuracy of community pathologists in the interpretation of colorectal polyps. Eur. J. Gastroenterol. Hepatol. 2009; 21; 1153-1160.
15. Terry MB, Neugut AI, Bostick RM, Potter JD, Haile RW, Fenoglio-Preiser CM. Reliability in the classification of advanced colorectal adenomas. Cancer Epidemiol. Biomarkers Prev. 2002; 11; 660-663.
16. Costantini M, Sciallero S, Giannini A et al. Interobserver agreement in the histologic diagnosis of colorectal polyps: the experience of the multicenter adenoma colorectal study (SMAC). J. Clin. Epidemiol. 2003; 56; 209-214.
17. Komuta K, Batts K, Jessurun J et al. Interobserver variability in the pathological assessment of malignant colorectal polyps. Br. J. Surg. 2004; 91; 1479-1484.
18. Reporting lesions in the NHS Bowel Cancer Screening Programme. Guidelines from the Bowel Cancer Screening Programme Pathology Group. NHS BCSP Publication no 1. Sheffield: NHS Cancer Screening Programmes, 2007.
19. Konishi F, Morson BC. Pathology of colorectal adenomas: a colonoscopic survey. J. Clin. Pathol. 1982; 35; 830-841.
20. van Putten PG, Lieke H, van Dekken H et al. Inter-observer variation in the histological diagnosis of polyps in colorectal cancer screening. Histopathology 2011; 58; 974-981.
21. Haggitt RC, Glotzbach RE, Soffer EE, Wruble LD. Prognostic factors in colorectal carcinomas arising in adenomas: implications for lesions removed by endoscopic polypectomy. Gastroenterology 1985; 89; 328-336.
22. Kikuchi R, Takano M, Takagi K et al. Management of early invasive colorectal cancer. Risk of recurrence and clinical guidelines. Dis. Colon Rectum 1995; 38; 1286-1295.
23. Ekelund G, Lindstrom C. Histopathological analysis of benign polyps in patients with carcinoma of the colon and rectum. Gut 1974; 15; 654-663.
24. Hamilton SR, Aaltonen LA. Pathology and genetics of tumours of the digestive system. World Health Organisation Classification of Tumours, vol 2, Lyon; IARC Press, 2000.